This was shared by AFA on FB. This is a great article on the risk of stroke in AF patients. It's worth reading....
online.wsj.com/article/PR-C...
Tim
This was shared by AFA on FB. This is a great article on the risk of stroke in AF patients. It's worth reading....
online.wsj.com/article/PR-C...
Tim
While there is a lot of true information in this, and some rather puzzling statements (e.g.'The survey did not ask the polled physicians for potential reasons why the true incidence of ischaemic stroke may be underestimated') I feel it should be pointed out that the source of this article 'Boehringer Ingelheim GmbH' is the registered owner of Pradaxa.
elmbury, I had not noticed that. But I did find a statement in the original article:
"The survey was conducted via a MedLIVETM PULSE to 1,000 GPs and Cardiologists in France, Germany, Spain, Italy, Belgium, The Netherlands and Ireland on behalf of Boehringer Ingelheim GmbH. The survey consisted of five key questions in English language, with responses received from 556 GPs and 444 Cardiologists. The survey explored factors affecting prescribing behaviours in atrial fibrillation, including the respective importance of treatment attributes and the perceived overall incidence of ischaemic stroke, and provided consensus on the need for ischaemic stroke prevention to become a treatment priority."
And I did find another thing... If you go to the original article, There is a picture of Trudie there. (the founder of AFA)
Thanks for pointing that out...
Tim
Thanks for the read Tim and we are always looking to educate ourselves more about our A Fib and possible harm it can give. Two parts jumped at me. Not for media of the UK, US or Canada. Why not? This also seems to be pushing one drug for blood thinning. A part says 'Pradaxa(R) 150mg bid provided a 35% reduction '
This tells me this was put out by a drug company, the one that has an interest in pradaxa. Although of course it is quite correct that the risk of stroke in A Fib patients is far higher than the general population and we should all be on some sort of anti coagulant therapy.
Thanks for the link Tim. Boehringer Ingleheim have always been keen on education and although they have a less than veiled interest, any research that makes clinicians stop and think what their objectives are must be to our advantage.
Thank you Tim for this; it was an read not to be missed. I guess the 2% figure of the population is probably higher than that as so many people are not diagnosed with AF.
I feel so much safer on Rivaroxaban knowing my risk of stroke has been reduced considerably.
Nikki
Like others I am puzzled by the omission of certain areas - but very interesting to read the article, and agree that the pharmaceutical companies are highly skilful at the promotion of their own products. I've decided to keep an open mind on most things and put my trust in the UK consultant and GP - no other choice. My condition was picked up by my GP following an operation earlier this year and he acted on it immediately with anti-coagulants and beta blockers whilst waiting for an appointment with a cardiologist which resulted in an unsuccessful cardioversion treatment. Will know more when I next visit the Hospital later this month, meanwhile continue to live life - and remember it's not the rehearsal...................
Ruuth
Ruuth,
It is refreshing to hear a story about a GP that took the right actions in dealing with your problem. I hear so many who deal with GPs and Drs (here in the US) that are just told it will go away, Don't worry about it and take an aspirin a day and you'll be fine.
Also you have a great attitude toward it. Make life great even when going over the speed bumps.
Tim